S1PR2 and systemic sclerosis: To this end, we established as a first step novel in vitro assays for detection and quantification of aAb binding to S1PR1, S1PR2 or S1PR3, and compared the prevalence of these GPCR-specific aAb in serum samples from healthy controls and SSc patients with or without PAH.